Posterior Polymorphous Corneal Dystrophy in a Pediatric Population

Abdelrahman M Elhusseiny1,2, Hajirah N Saeed1,2

  • 1Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, MA; and.

Cornea
|September 1, 2021
PubMed

Insights

Posterior polymorphous corneal dystrophy (PPCD) often presents unilaterally in children, causing astigmatism and amblyopia. Early diagnosis and regular follow-ups are crucial for managing this rare genetic eye condition.

Area of Science:

  • Ophthalmology
  • Genetics
  • Pediatric Eye Care

Background:

  • Posterior polymorphous corneal dystrophy (PPCD) is a rare, inherited eye disorder.
  • It affects the cornea's innermost layers, potentially leading to vision impairment.
  • Understanding its presentation in children is vital for timely intervention.

Purpose of the Study:

  • To evaluate the clinical and topographic features of PPCD in pediatric patients (≤15 years).
  • To assess long-term outcomes and identify key diagnostic indicators in children.
  • To compare affected eyes with unaffected contralateral eyes in unilateral cases.

Main Methods:

  • Retrospective case series of pediatric PPCD patients diagnosed between 1999-2020.
  • Data included demographics, clinical findings (slit lamp, refraction, visual acuity), corneal topography, and specular microscopy.
  • Analysis focused on differences between affected and unaffected eyes in unilateral cases.

Main Results:

  • Nineteen patients (27 eyes) with PPCD were analyzed; 11 cases were unilateral.
  • Affected eyes showed significant differences in endothelial cell density and hexagonality compared to unaffected eyes.
  • Initial presentation included astigmatism and amblyopia, with resolution in some cases after treatment.

Conclusions:

  • PPCD can manifest early in children, presenting with astigmatism and anisometropic amblyopia.
  • Unilateral presentation is more common in children than adults.
  • Regular monitoring with slit lamp exams and cycloplegic retinoscopy is essential for early detection and management of refractive amblyopia.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
47
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.9K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
36